Moderna-vaccinated deaths up to 50% higher than Pfizer, official...

Steve Kirsch’s analysis of Czech government data suggests that the Moderna vaccine was associated with significantly higher mortality rates compared to Pfizer’s vaccine. By using the Pfizer cohort as a placebo control, the study isolates the impact of the vaccine on mortality, revealing that Moderna recipients faced substantially higher death rates, particularly among younger populations where background mortality is low. This finding implies that the observed differences are likely due to vaccine safety rather than differing levels of efficacy against the virus. The consistency of these results across varying periods of high and low community infection rates strengthens the conclusion that the excess deaths were not caused by external factors like widespread illness. If the disparity were due to the vaccines' ability to prevent disease, the gap would have narrowed during periods with low transmission. Instead, the elevated mortality risk for Moderna users remained constant, pointing toward an intrinsic safety issue with that specific vaccine brand rather than its performance against infection. This case highlights the critical importance of open, granular health data for independent scientific scrutiny. By making detailed, record-level information publicly accessible through freedom of information requests, researchers can perform rigorous, real-world safety analyses that are difficult to conduct in controlled clinical trials. This transparency empowers scientists to verify official narratives and identify potential public health risks, demonstrating how open data serves as a vital check on institutional power and patient safety.

Source: sott.net
Published on 2024-07-20

Mistral AI, Nvidia debut new enterprise AI model - IT-Online »

Open Data

Related news